Jean-Philippe Couderc
Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Electrocardiography | 34 | 1995 | 132 |
Why?
|
Long QT Syndrome | 19 | 1996 | 35 |
Why?
|
Electrocardiography, Ambulatory | 11 | 1996 | 23 |
Why?
|
Heart Rate | 25 | 1996 | 138 |
Why?
|
Heart Conduction System | 7 | 2001 | 37 |
Why?
|
Telemetry | 4 | 2007 | 19 |
Why?
|
Arrhythmias, Cardiac | 7 | 2001 | 65 |
Why?
|
Sotalol | 5 | 2003 | 6 |
Why?
|
Ether-A-Go-Go Potassium Channels | 4 | 2006 | 9 |
Why?
|
Aza Compounds | 6 | 2006 | 13 |
Why?
|
Quinolines | 6 | 2006 | 26 |
Why?
|
Signal Processing, Computer-Assisted | 10 | 1995 | 39 |
Why?
|
Databases as Topic | 2 | 2010 | 27 |
Why?
|
Diagnosis, Computer-Assisted | 3 | 2007 | 39 |
Why?
|
Anti-Infective Agents | 5 | 2006 | 54 |
Why?
|
Mutation | 8 | 1998 | 340 |
Why?
|
Tachycardia, Ventricular | 5 | 1995 | 25 |
Why?
|
Anti-Arrhythmia Agents | 3 | 2007 | 36 |
Why?
|
Models, Cardiovascular | 2 | 2006 | 40 |
Why?
|
Torsades de Pointes | 2 | 2007 | 16 |
Why?
|
Ventricular Function | 2 | 2001 | 23 |
Why?
|
Information Dissemination | 1 | 2010 | 19 |
Why?
|
Reproducibility of Results | 9 | 1996 | 391 |
Why?
|
Channelopathies | 1 | 2010 | 11 |
Why?
|
User-Computer Interface | 1 | 2010 | 36 |
Why?
|
Biomedical Technology | 1 | 2010 | 3 |
Why?
|
Humans | 41 | 1995 | 1856 |
Why?
|
Sodium Channels | 3 | 1998 | 32 |
Why?
|
Databases, Factual | 1 | 2010 | 102 |
Why?
|
Health Plan Implementation | 1 | 2010 | 20 |
Why?
|
Delayed Rectifier Potassium Channels | 2 | 2006 | 8 |
Why?
|
Artifacts | 2 | 1996 | 34 |
Why?
|
Algorithms | 5 | 1995 | 226 |
Why?
|
Male | 31 | 1995 | 1553 |
Why?
|
Defibrillators, Implantable | 4 | 2001 | 35 |
Why?
|
Ventricular Dysfunction | 1 | 2008 | 8 |
Why?
|
Heart Diseases | 1 | 2010 | 92 |
Why?
|
Heart Ventricles | 1 | 2009 | 86 |
Why?
|
Female | 26 | 1995 | 1643 |
Why?
|
Ventricular Fibrillation | 1 | 2007 | 24 |
Why?
|
Air Pollutants | 3 | 2001 | 42 |
Why?
|
Adult | 18 | 1995 | 1317 |
Why?
|
DNA | 1 | 2011 | 262 |
Why?
|
Sensitivity and Specificity | 6 | 1995 | 427 |
Why?
|
Models, Biological | 1 | 2011 | 410 |
Why?
|
Myocardial Infarction | 6 | 1995 | 129 |
Why?
|
Genetic Predisposition to Disease | 2 | 1999 | 131 |
Why?
|
Logistic Models | 3 | 2006 | 251 |
Why?
|
Access to Information | 2 | 2010 | 4 |
Why?
|
Predictive Value of Tests | 5 | 2001 | 321 |
Why?
|
Risk Factors | 5 | 1995 | 555 |
Why?
|
Middle Aged | 16 | 1995 | 1161 |
Why?
|
Air Pollution | 2 | 2005 | 17 |
Why?
|
Cardiovascular Diseases | 1 | 2001 | 127 |
Why?
|
Autonomic Nervous System | 3 | 2001 | 41 |
Why?
|
Follow-Up Studies | 5 | 1998 | 553 |
Why?
|
Phenotype | 3 | 1998 | 303 |
Why?
|
Heart | 3 | 2001 | 88 |
Why?
|
Retrospective Studies | 2 | 2008 | 653 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2011 | 2 |
Why?
|
Cardiotoxins | 1 | 2011 | 3 |
Why?
|
Imidazoles | 1 | 2011 | 47 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2011 | 10 |
Why?
|
Data Mining | 1 | 2010 | 3 |
Why?
|
Piperazines | 1 | 2011 | 57 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 65 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2001 | 35 |
Why?
|
Carbon | 2 | 2005 | 30 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 110 |
Why?
|
Proportional Hazards Models | 3 | 2001 | 123 |
Why?
|
Death, Sudden, Cardiac | 2 | 2006 | 31 |
Why?
|
Guidelines as Topic | 1 | 2011 | 77 |
Why?
|
Placebos | 2 | 2006 | 110 |
Why?
|
Program Development | 1 | 2010 | 61 |
Why?
|
Coronary Occlusion | 1 | 2009 | 1 |
Why?
|
Genotype | 1 | 2011 | 175 |
Why?
|
Internet | 1 | 2010 | 64 |
Why?
|
Coronary Artery Disease | 1 | 2010 | 56 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2009 | 11 |
Why?
|
Cooperative Behavior | 1 | 2010 | 70 |
Why?
|
Potassium Channels | 1 | 2010 | 33 |
Why?
|
Adolescent | 4 | 1999 | 891 |
Why?
|
ROC Curve | 2 | 2003 | 80 |
Why?
|
Equipment Design | 1 | 2010 | 132 |
Why?
|
Surface Properties | 1 | 2009 | 63 |
Why?
|
Sex Factors | 1 | 2011 | 284 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2009 | 29 |
Why?
|
Software | 1 | 2009 | 92 |
Why?
|
Central Nervous System | 1 | 2009 | 77 |
Why?
|
Romano-Ward Syndrome | 1 | 2007 | 7 |
Why?
|
Time Factors | 4 | 2001 | 896 |
Why?
|
Terfenadine | 1 | 2006 | 3 |
Why?
|
Reference Values | 1 | 2008 | 278 |
Why?
|
Models, Statistical | 1 | 2009 | 114 |
Why?
|
Vehicle Emissions | 1 | 2007 | 14 |
Why?
|
Anti-Allergic Agents | 1 | 2006 | 5 |
Why?
|
Environmental Exposure | 1 | 2009 | 75 |
Why?
|
Echocardiography | 1 | 2007 | 93 |
Why?
|
Cross-Over Studies | 3 | 2009 | 82 |
Why?
|
Inhalation Exposure | 1 | 2007 | 22 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2006 | 24 |
Why?
|
Dogs | 1 | 2006 | 159 |
Why?
|
Aged | 6 | 2001 | 988 |
Why?
|
Regression Analysis | 2 | 2001 | 256 |
Why?
|
Action Potentials | 1 | 2006 | 77 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 431 |
Why?
|
Blood Pressure | 1 | 2007 | 205 |
Why?
|
Research Design | 1 | 2006 | 169 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 62 |
Why?
|
Hypertension | 1 | 2007 | 161 |
Why?
|
Particle Size | 3 | 2005 | 55 |
Why?
|
Aging | 1 | 2007 | 275 |
Why?
|
Heterozygote Detection | 1 | 1999 | 16 |
Why?
|
Fourier Analysis | 2 | 1995 | 23 |
Why?
|
Statistics, Nonparametric | 3 | 2001 | 141 |
Why?
|
Analysis of Variance | 2 | 1996 | 339 |
Why?
|
Double-Blind Method | 2 | 2009 | 274 |
Why?
|
Postoperative Complications | 1 | 2001 | 305 |
Why?
|
Automatic Data Processing | 1 | 1996 | 7 |
Why?
|
Young Adult | 2 | 2009 | 380 |
Why?
|
Zinc Fingers | 1 | 1995 | 20 |
Why?
|
Coronary Disease | 1 | 1998 | 94 |
Why?
|
Drosophila melanogaster | 1 | 1995 | 26 |
Why?
|
Drosophila Proteins | 1 | 1995 | 23 |
Why?
|
Animals | 3 | 1995 | 1031 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1996 | 138 |
Why?
|
Child, Preschool | 1 | 1999 | 554 |
Why?
|
Survival Analysis | 2 | 2003 | 205 |
Why?
|
Triazines | 1 | 2011 | 20 |
Why?
|
Sulfones | 1 | 2011 | 23 |
Why?
|
Automation, Laboratory | 1 | 2011 | 1 |
Why?
|
Tachycardia | 1 | 2011 | 32 |
Why?
|
Ion Channels | 2 | 2001 | 61 |
Why?
|
Observer Variation | 1 | 2011 | 103 |
Why?
|
Child | 1 | 1999 | 749 |
Why?
|
Prognosis | 2 | 2001 | 388 |
Why?
|
Particulate Matter | 1 | 2010 | 22 |
Why?
|
Linear Models | 1 | 2011 | 151 |
Why?
|
DNA-Binding Proteins | 1 | 1995 | 204 |
Why?
|
Transcription Factors | 1 | 1995 | 201 |
Why?
|
Silicones | 1 | 2009 | 20 |
Why?
|
Death, Sudden | 1 | 2009 | 23 |
Why?
|
Discriminant Analysis | 1 | 2007 | 21 |
Why?
|
Exercise | 1 | 2009 | 82 |
Why?
|
Treatment Outcome | 2 | 2001 | 661 |
Why?
|
Rats, Inbred SHR | 1 | 2007 | 24 |
Why?
|
Injections, Intraperitoneal | 1 | 2007 | 57 |
Why?
|
Automobile Driving | 1 | 2007 | 19 |
Why?
|
Multivariate Analysis | 1 | 2009 | 225 |
Why?
|
Aerosols | 1 | 2007 | 39 |
Why?
|
Administration, Inhalation | 1 | 2007 | 60 |
Why?
|
Stents | 1 | 2009 | 55 |
Why?
|
Stroke Volume | 1 | 2006 | 54 |
Why?
|
Germany | 1 | 2005 | 21 |
Why?
|
Lipopolysaccharides | 1 | 2007 | 98 |
Why?
|
Cost-Benefit Analysis | 1 | 2006 | 118 |
Why?
|
Age Factors | 1 | 2007 | 480 |
Why?
|
Inflammation | 1 | 2007 | 208 |
Why?
|
Principal Component Analysis | 1 | 2001 | 18 |
Why?
|
Fractals | 1 | 2001 | 5 |
Why?
|
Heterozygote | 1 | 2001 | 80 |
Why?
|
Exercise Test | 1 | 2001 | 51 |
Why?
|
Nonlinear Dynamics | 1 | 2001 | 18 |
Why?
|
Prospective Studies | 1 | 2006 | 545 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2001 | 47 |
Why?
|
Societies, Medical | 1 | 2001 | 90 |
Why?
|
Case-Control Studies | 1 | 2001 | 283 |
Why?
|
Rats | 1 | 2007 | 530 |
Why?
|
Coronary Angiography | 1 | 1998 | 49 |
Why?
|
Peptide Mapping | 1 | 1995 | 27 |
Why?
|
Protein Folding | 1 | 1995 | 30 |
Why?
|
Sequence Alignment | 1 | 1995 | 114 |
Why?
|
Heart Arrest | 1 | 1995 | 37 |
Why?
|
Amino Acid Sequence | 1 | 1995 | 319 |
Why?
|
Base Sequence | 1 | 1995 | 371 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 404 |
Why?
|
